Warm Springs Advisors’s Boston Scientific BSX Stock Holding History

Warm Springs Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,635	Closed	-$416K	–	47
2026 Q1	$416K	Hold	6,635	–	–	0.35%	44
2025 Q4	$633K	Hold	6,635	–	–	0.49%	36
2025 Q3	$648K	Hold	6,635	–	–	0.49%	36
2025 Q2	$713K	Sell	6,635 -991	-13%	-$100K	0.61%	33
2025 Q1	$769K	Buy	7,626 +330	+5%	+$33.2K	0.77%	34
2024 Q4	$652K	Buy	+7,296	New	+$642K	0.6%	37

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Warm Springs Advisors's BSX Position: Q2 2026 in Review

Warm Springs Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,635 shares — an estimated $416K sold.

Warm Springs Advisors first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $769K in Q1 2025. 1,486 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Warm Springs Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Warm Springs Advisors sold 6,635 Boston Scientific shares in Q2 2026, an estimated $416K.
Warm Springs Advisors first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
Warm Springs Advisors's Boston Scientific position peaked at $769K in Q1 2025.
1,486 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Warm Springs Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.